[go: up one dir, main page]

AU2001236099A1 - Rfrp-containing prolactin secretion regulatory agent - Google Patents

Rfrp-containing prolactin secretion regulatory agent

Info

Publication number
AU2001236099A1
AU2001236099A1 AU2001236099A AU3609901A AU2001236099A1 AU 2001236099 A1 AU2001236099 A1 AU 2001236099A1 AU 2001236099 A AU2001236099 A AU 2001236099A AU 3609901 A AU3609901 A AU 3609901A AU 2001236099 A1 AU2001236099 A1 AU 2001236099A1
Authority
AU
Australia
Prior art keywords
rfrp
regulatory agent
prolactin secretion
secretion regulatory
containing prolactin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236099A
Inventor
Yugo Habata
Shuji Hinuma
Yoshio Matsumoto
Takuya Watanabe
Hiromi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001236099A1 publication Critical patent/AU2001236099A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/5756Prolactin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
AU2001236099A 2000-03-06 2001-03-06 Rfrp-containing prolactin secretion regulatory agent Abandoned AU2001236099A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000065752 2000-03-06
JP2000-065752 2000-03-06
JP2000378001 2000-12-07
JP2000-378001 2000-12-07
PCT/JP2001/001716 WO2001066134A1 (en) 2000-03-06 2001-03-06 Rfrp-containing prolactin secretion regulatory agent

Publications (1)

Publication Number Publication Date
AU2001236099A1 true AU2001236099A1 (en) 2001-09-17

Family

ID=26587133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236099A Abandoned AU2001236099A1 (en) 2000-03-06 2001-03-06 Rfrp-containing prolactin secretion regulatory agent

Country Status (4)

Country Link
EP (1) EP1262190A4 (en)
AU (1) AU2001236099A1 (en)
CA (1) CA2401946A1 (en)
WO (1) WO2001066134A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046405A1 (en) * 2000-12-07 2002-06-13 Takeda Chemical Industries, Ltd. Process for producing rfrp
US7041789B2 (en) 2001-08-24 2006-05-09 Takeda Pharmaceutical Company Limited RFRP-3 and DNA thereof
EP1424392B1 (en) * 2001-09-03 2012-10-24 Takeda Pharmaceutical Company Limited RF-peptide ligands of G-protein coupled receptor
AU2003254867A1 (en) * 2002-08-09 2004-02-25 Takeda Pharmaceutical Company Limited Novel uses of rfrp and ot7t022
WO2004083184A1 (en) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited Receptor antagonist
WO2004089399A1 (en) * 2003-04-01 2004-10-21 Takeda Pharmaceutical Company Limited Novel uses of rfrp and ot7t022
WO2009033779A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Nociceptin for use as a therapeutic agent
WO2012133825A1 (en) * 2011-03-31 2012-10-04 株式会社資生堂 Hot flash suppressant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636437T2 (en) * 1995-12-28 2007-03-15 Takeda Pharmaceutical Co. Ltd. LIGAND POLYPEPTIDE FOR HYPOPHYSE G PROTEIN COUPLED RECEPTOR PROTEIN, THEIR PREPARATION AND APPLICATION
AU8037398A (en) * 1997-06-23 1999-01-04 Takeda Chemical Industries Ltd. Prolactin secretion modulator
WO2000029441A1 (en) * 1998-11-13 2000-05-25 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein, its dna and ligand thereof
CA2430082A1 (en) * 2000-11-29 2002-06-06 Lynkeus Biotech Gmbh Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
WO2002046405A1 (en) * 2000-12-07 2002-06-13 Takeda Chemical Industries, Ltd. Process for producing rfrp

Also Published As

Publication number Publication date
CA2401946A1 (en) 2001-09-13
WO2001066134A1 (en) 2001-09-13
EP1262190A1 (en) 2002-12-04
EP1262190A4 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
AU2001264256A1 (en) Plaster
AU2002216028A1 (en) Novel carbamate-substituted pyrazolopyridine derivatives
AU2002221827A1 (en) Novel lactame-substituted pyrazolopyridine derivatives
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2023301A (en) Improved prosthesis
AU2001252679A1 (en) Plaster
AU2001220246A1 (en) Neckphone
EP1151667A3 (en) Plant-activating agent
AU2001268750A1 (en) Flushed-seal respirator
AU2002234010A1 (en) Benzamidine derivatives
AU3175900A (en) Tampon
AU2001220281A1 (en) Rollerboard for road-skiing
AU2001240557A1 (en) Implant for cranioplastics
AU2001236099A1 (en) Rfrp-containing prolactin secretion regulatory agent
AU1554301A (en) Radioprotecting agent
AU2001276354A1 (en) Hetaryl-substituted heterocycles
AU2001283156A1 (en) Polymorph-enriched ets-4
AU2001218611A1 (en) Stent
AUPR099200A0 (en) New formulation
AU6711500A (en) Dressing
AU2001231450A1 (en) Roundness standard
AU2542100A (en) Protease
AU1686500A (en) Mask
WO2002053739A8 (en) Neuropilin homolog zcub5
AU5576300A (en) Billiard table